These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 22832429)

  • 1. Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
    Mamdani F; Berlim MT; Beaulieu MM; Labbe A; Merette C; Turecki G
    Transl Psychiatry; 2011 Jun; 1(6):e13. PubMed ID: 22832429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.
    Mamdani F; Berlim MT; Beaulieu MM; Turecki G
    World J Biol Psychiatry; 2014 Feb; 15(2):135-44. PubMed ID: 23530732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ
    Pharmacogenet Genomics; 2008 Oct; 18(10):869-75. PubMed ID: 18794724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of BDNF expression according to antidepressant response.
    Lopez JP; Mamdani F; Labonte B; Beaulieu MM; Yang JP; Berlim MT; Ernst C; Turecki G
    Mol Psychiatry; 2013 Apr; 18(4):398-9. PubMed ID: 22547115
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
    Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
    Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
    BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report.
    Allen TA; Lam RW; Milev R; Rizvi SJ; Frey BN; MacQueen GM; Müller DJ; Uher R; Kennedy SH; Quilty LC
    Psychol Med; 2019 Jul; 49(10):1629-1638. PubMed ID: 30220263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
    Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
    Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
    Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.
    Brennan BP; Admon R; Perriello C; LaFlamme EM; Athey AJ; Pizzagalli DA; Hudson JI; Pope HG; Jensen JE
    Psychiatry Res Neuroimaging; 2017 Nov; 269():9-16. PubMed ID: 28892734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1.
    Wang X; Wang B; Zhao J; Liu C; Qu X; Li Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30482883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genomewide association study of citalopram response in major depressive disorder.
    Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment.
    Yamagata B; Yamanaka K; Takei Y; Hotta S; Hirano J; Tabuchi H; Mimura M
    J Affect Disord; 2019 Jun; 252():25-31. PubMed ID: 30959413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder.
    Milanesi E; Minelli A; Cattane N; Cattaneo A; Mora C; Barbon A; Mallei A; Popoli M; Florio V; Conca A; Bignotti S; Gennarelli M
    BMC Psychiatry; 2012 Sep; 12():145. PubMed ID: 22989054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.
    Möller HJ; Demyttenaere K; Olausson B; Szamosi J; Wilson E; Hosford D; Dunbar G; Tummala R; Eriksson H
    World J Biol Psychiatry; 2015 Oct; 16(7):483-501. PubMed ID: 25602163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between whole-body heating and citalopram on body temperature, antidepressant-like behaviour, and neurochemistry in adolescent male rats.
    Hale MW; Lukkes JL; Dady KF; Kelly KJ; Paul ED; Smith DG; Heinze JD; Raison CL; Lowry CA
    Behav Brain Res; 2019 Feb; 359():428-439. PubMed ID: 30468787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response.
    Fiori LM; Orri M; Aouabed Z; Théroux JF; Lin R; Nagy C; Frey BN; Lam RW; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Uher R; Foster JA; Kennedy SH; Turecki G
    Transl Psychiatry; 2021 Aug; 11(1):439. PubMed ID: 34420030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.